Unknown

Dataset Information

Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events.


ABSTRACT:

Background

Adverse events (AEs) in clinical trials may be reported in multiple sources. Different methods for reporting adverse events across trials or across sources for a single trial may produce inconsistent information about the adverse events associated with interventions.

Methods

We compared the methods authors use to decide which AEs to include in a particular source (i.e., "selection criteria"), including the number of different types of AEs reported (i.e., rather than the number of events). We compared sources (e.g., journal articles, clinical study reports (CSRs)) of trials for two drug-indications-gabapentin for neuropathic pain and quetiapine for bipolar depression. Electronic searches were completed in 2015. We identified selection criteria and assessed how crit

SUBMITTER: Mayo-Wilson E 

PROVIDER: S-EPMC6728982 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature